Total Return chart Theraclion

Equities

Real-time Euronext Paris Other stock markets 08:22:02 2024-05-13 am EDT			5-day change	1st Jan Change
0.512 ^EUR	-1.92%		+38.38%	+31.96%

Mar. 27	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.